Skip to main content

Advertisement

SpringerLink
Log in

One-year disease-related health care costs of incident vertebral fractures in osteoporotic patients

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

The study aims to estimate the direct disease-related costs of osteoporotic vertebral compression fractures (OVCF) in patients with newly diagnosed fracture in the first year after index in Germany. Analyses reveal that OVCFs are associated with significant costs. In light of high and increasing incidence, the results emphasize importance of research in this field.

Introduction

OVCF are among the most common fractures related to osteoporosis. They have been shown to be associated with excess mortality and meaningful healthcare costs. Costs calculations have illustrated the significant financial burden to society and national social security systems. However, this information is not available for Germany. Therefore, aim of the study was to estimate the direct disease-related costs of OVCF in patients with newly diagnosed fracture in the first year after index in Germany.

Methods

Data were obtained from a claims dataset of a large German health insurance fund. Subjects ≥60 years with a new vertebral fracture between 2006 and 2010 were studied retrospectively compared to a matched paired OVCF-free patient group. All-cause and fracture-specific medical costs were calculated in the 1-year baseline and follow-up period. Generalized linear model (GLM) was estimated for total follow-up healthcare cost.

Results

A total of 2,277 pairs of matched OVCF and OVCF-free patients were included in the analysis. Baseline costs were higher in the OVCF group. Mean unadjusted all-cause healthcare cost difference in the four quarters following the index date between OVCF and OVCF-free patients was 8,200 € (p < 0.001). Of the difference, almost two third was attributable to inpatient services and one quarter to prescription drug costs. The GLM procedure revealed that OVCF-related costs in the first year after the index date add up to 6,490 € (p < 0.001; CI 5,809 €–6,731 €).

Conclusions

Despite limitations of this study, our results are consistent with other research and demonstrate that OVCFs are associated with significant costs. The results underline the importance of medical interventions that can help to prevent fractures and treatments, which are cost-effective and can prevent recurrent fractures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. (1991) Consensus development conference: prophylaxis and treatment of osteoporosis. The American Journal of Medicine 90:107–110. doi: 10.1016/0002-9343(91)90512-V

  2. Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D (2007) Epidemiology, treatment and costs of osteoporosis in Germany—the BoneEVA Study. Osteoporos Int 18:77–84. doi:10.1007/s00198-006-0206-y

    Article  PubMed  Google Scholar 

  3. Becker S, Ogon M (2006) Balloon kyphoplasty. Springer, Wien

    Google Scholar 

  4. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733

    Article  PubMed  CAS  Google Scholar 

  5. Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277–1288. doi:10.1007/s00198-011-1601-6

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jónsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6:59–155. doi:10.1007/s11657-011-0060-1

    Article  PubMed  Google Scholar 

  7. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos 8. doi: 10.1007/s11657-013-0136-1

  8. Lau E, Ong KL, Kurtz SM, Schmier J, Edidin AA (2008) Mortality following the diagnosis of a vertebral compression fracture in the Medicare population. J Bone Joint Surg Am 90:1479–1486

    Article  PubMed  Google Scholar 

  9. Dimai H, Redlich K, Peretz M, Borgström F, Siebert U, Mahlich J (2012) Economic burden of osteoporotic fractures in Austria. Health Econ Rev 2:12. doi:10.1186/2191-1991-2-12

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sedrine WB, Radican L, Raginster J (2001) On conducting burden-of-osteoporosis studies: a review of the core concepts and practical issues. A study carried out under the auspices of a WHO Collaborating Center. Rheumatology 40:7–14. doi:10.1093/rheumatology/40.1.7

    Article  PubMed  Google Scholar 

  11. Lange A, Kasperk C, Alvares L, Sauermann S, Braun S (2014) Survival and cost comparison of kyphoplasty and percutaneous vertebroplasty using German claims data. Spine 39:318–326. doi: 10.1097/BRS.0000000000000135

  12. Kassenärztliche Bundesvereinigung (ed) (2008) Erweiterter Bewertungsausschuss nach § 87 Abs. 4 SGB V—7. Sitzung, 27./28. August 2008; Teil A zur erstmaligen Festlegung des Orientierungswertes nach § 87 Abs. 2e Satz 1 Nr. 1 SGB V für das Jahr 2009. 2008

  13. Prenzler A, Zeidler J, Braun S, Schulenburg J (2010) Bewertung von Ressourcen im Gesundheitswesen aus der Perspektive der deutschen Sozialversicherung. Pharmacoeconomics Ger Res Art 8:47–66. doi:10.1007/BF03320765

    Article  Google Scholar 

  14. Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27

    Article  PubMed  CAS  Google Scholar 

  15. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10. Med Care 43:1130–1139

    Article  PubMed  Google Scholar 

  16. van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ (2009) A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 47:626–633. doi:10.1097/MLR.0b013e31819432e5

    Article  PubMed  Google Scholar 

  17. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  PubMed  CAS  Google Scholar 

  18. Ho DE, Imai K, King G, Stuart EA (2006) Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Polit Anal 15:199–236. doi:10.1093/pan/mpl013

    Article  Google Scholar 

  19. Manning WG, Mullahy J (2001) Estimating log models: to transform or not to transform? J Health Econ 20:461–494. doi:10.1016/S0167-6296(01)00086-8

    Article  PubMed  CAS  Google Scholar 

  20. Pregibon D (1980) Goodness of link tests for generalized linear models. J R Stat Soc: Ser C: Appl Stat 29:15–24. doi:10.2307/2346405

    Google Scholar 

  21. Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley-Interscience, New York

  22. Wedderburn RW (1974) Quasi-likelihood functions, generalized linear models, and the Gauss-Newton method. Biometrika 61:439–447. doi:10.2307/2334725

    Google Scholar 

  23. Manning WG (1998) The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 17:283–295. doi:10.1016/S0167-6296(98)00025-3

    Article  PubMed  CAS  Google Scholar 

  24. Glick HA, Doshi JA, Sonnad SS, Polsky D (2007) Economic evaluation in clinical trials. Oxford Univ. Press, Oxford

    Google Scholar 

  25. Wooldridge JM (2010) Econometric analysis of cross section and panel data, 2nd edn. MIT Press, Cambridge

    Google Scholar 

  26. Gabriel SE, Tosteson AN, Leibson CL, Crowson CS, Pond GR, Melton LJ, Hammond CS (2002) Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 13:323–330

    Article  PubMed  CAS  Google Scholar 

  27. Ray NF, Chan JK, Thamer M, Melton LJ (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24–35. doi:10.1359/jbmr.1997.12.1.24

    Article  PubMed  CAS  Google Scholar 

  28. de Laet CE, van Hout BA, Burger H, Weel AE, Hofman A, Pols HA (1999) Incremental cost of medical care after hip fracture and first vertebral fracture. The Rotterdam study. Osteoporos Int 10:66–72

    Article  PubMed  Google Scholar 

  29. Shi N, Foley K, Lenhart G, Badamgarav E (2009) Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures. Bone 45:1084–1090. doi:10.1016/j.bone.2009.07.086

    Article  PubMed  Google Scholar 

  30. Rousculp MD, Long SR, Wang S, Schoenfeld MJ, Meadows ES (2007) Economic burden of osteoporosis-related fractures in Medicaid. Value Health 10:144–152. doi:10.1111/j.1524-4733.2006.00161.x

    Article  PubMed  Google Scholar 

  31. Rovithis D (2013) Do health economic evaluations using observational data provide reliable assessment of treatment effects? Health Econ Rev 3:21. doi:10.1186/2191-1991-3-21

    Article  PubMed  PubMed Central  Google Scholar 

  32. Rubin DB (1973) The use of matched sampling and regression adjustment to remove bias in observational studies. Biometrics 29:185–203. doi:10.2307/2529685

    Article  Google Scholar 

  33. Borgström F (2006) Health economics of osteoporosis, Stockholm

  34. Borgström F, Sobocki P, Strom O, Jonsson B (2007) The societal burden of osteoporosis in Sweden. Bone 40:1602–1609. doi:10.1016/j.bone.2007.02.027

    Article  PubMed  Google Scholar 

  35. Ong KL, Lau E, Kemner JE, Kurtz SM (2013) Two-year cost comparison of vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: are initial surgical costs misleading? Osteoporos Int 24:1437–1445. doi:10.1007/s00198-012-2100-0

    Article  PubMed  CAS  Google Scholar 

  36. Stuart EA (2010) Matching methods for causal inference: a review and a look forward. Stat Sci 25:1–21. doi:10.1214/09-STS313

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Conflicts of interest

None.

The study was funded by an unrestricted grant from Medtronic International. Herescon GmbH has received payment from Medtronic.

Author information

Authors and Affiliations

  1. Center for Health Economics Research Hannover (CHERH), Leibniz University Hannover, Koenigsworther Platz 1, 30167, Hannover, Germany

    A. Lange & J. Zeidler

  2. Herescon GmbH—Health Economic Research & Consulting, Hannover, Germany

    S. Braun

Authors
  1. A. Lange
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Zeidler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Lange.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lange, A., Zeidler, J. & Braun, S. One-year disease-related health care costs of incident vertebral fractures in osteoporotic patients. Osteoporos Int 25, 2435–2443 (2014). https://doi.org/10.1007/s00198-014-2776-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-014-2776-4

Keywords

Search

Navigation